while the 36-month beta value is 2.20.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for SPPI is 184.03M, and currently, short sellers hold a 2.48% ratio of that floaft. The average trading volume of SPPI on March 16, 2023 was 1.97M shares.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
SPPI) stock’s latest price update
Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI)’s stock price has decreased by -6.64 compared to its previous closing price of 0.83. Nevertheless, the company has seen a -12.08% plunge in its stock price over the last five trading sessions.
SPPI’s Market Performance
SPPI’s stock has fallen by -12.08% in the past week, with a monthly drop of -15.77% and a quarterly rise of 72.39%. The volatility ratio for the week is 11.23% while the volatility levels for the last 30 days are 9.03% for Spectrum Pharmaceuticals Inc. The simple moving average for the last 20 days is -7.69% for SPPI stock, with a simple moving average of 7.48% for the last 200 days.
Analysts’ Opinion of SPPI
Many brokerage firms have already submitted their reports for SPPI stocks, with JMP Securities repeating the rating for SPPI by listing it as a “Mkt Outperform.” The predicted price for SPPI in the upcoming period, according to JMP Securities is $12 based on the research report published on September 17th of the previous year 2020.
Cantor Fitzgerald gave a rating of “Neutral” to SPPI, setting the target price at $4 in the report published on December 26th of the previous year.
SPPI Trading at 7.84% from the 50-Day Moving Average
After a stumble in the market that brought SPPI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -50.64% of loss for the given period.
Volatility was left at 9.03%, however, over the last 30 days, the volatility rate increased by 11.23%, as shares sank -16.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +110.28% upper at present.
During the last 5 trading sessions, SPPI fell by -12.08%, which changed the moving average for the period of 200-days by +9.17% in comparison to the 20-day moving average, which settled at $0.8318. In addition, Spectrum Pharmaceuticals Inc. saw 110.28% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SPPI starting from McGahan Keith M, who sale 18,385 shares at the price of $0.77 back on Feb 23. After this action, McGahan Keith M now owns 618,312 shares of Spectrum Pharmaceuticals Inc., valued at $14,156 using the latest closing price.
Riga Thomas J, the CEO & President of Spectrum Pharmaceuticals Inc., sale 37,009 shares at $0.77 during a trade that took place back on Feb 22, which means that Riga Thomas J is holding 1,839,639 shares at $28,365 based on the most recent closing price.
Stock Fundamentals for SPPI
Equity return is now at value -246.70, with -103.60 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.95.
Conclusion
In a nutshell, Spectrum Pharmaceuticals Inc. (SPPI) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
